BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27016707)

  • 1. Novel spiropyrazolone antitumor scaffold with potent activity: Design, synthesis and structure-activity relationship.
    Wu S; Li Y; Xu G; Chen S; Zhang Y; Liu N; Dong G; Miao C; Su H; Zhang W; Sheng C
    Eur J Med Chem; 2016 Jun; 115():141-7. PubMed ID: 27016707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of novel antitumor spirotetrahydrothiopyran-oxindole derivatives as potent p53-MDM2 inhibitors.
    Ji C; Wang S; Chen S; He S; Jiang Y; Miao Z; Li J; Sheng C
    Bioorg Med Chem; 2017 Oct; 25(20):5268-5277. PubMed ID: 28797774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro.
    Wang J; Ge R; Qiu X; Xu X; Wei L; Li Z; Bian J
    Eur J Med Chem; 2017 Nov; 140():421-434. PubMed ID: 28987604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An organocatalytic asymmetric double Michael cascade reaction of unsaturated ketones and unsaturated pyrazolones: highly efficient synthesis of spiropyrazolone derivatives.
    Liang J; Chen Q; Liu L; Jiang X; Wang R
    Org Biomol Chem; 2013 Mar; 11(9):1441-5. PubMed ID: 23262465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core scaffold-inspired stereoselective synthesis of spiropyrazolones via an organocatalytic Michael/cyclization sequence.
    Liu L; Zhong Y; Zhang P; Jiang X; Wang R
    J Org Chem; 2012 Nov; 77(22):10228-34. PubMed ID: 23072426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption.
    Yugandhar D; Nayak VL; Archana S; Shekar KC; Srivastava AK
    Eur J Med Chem; 2015 Aug; 101():348-57. PubMed ID: 26163220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules.
    Lu Y; Wang L; Wang X; Xi T; Liao J; Wang Z; Jiang F
    Eur J Med Chem; 2017 Jul; 135():125-141. PubMed ID: 28441581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient and regioselective synthesis of novel functionalized dispiropyrrolidines and their cytotoxic activities.
    Yang JM; Hu Y; Li Q; Yu F; Cao J; Fang D; Huang ZB; Shi DQ
    ACS Comb Sci; 2014 Mar; 16(3):139-45. PubMed ID: 24517857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 4,5-dihydrospiro[benzo[c]azepine-1,1'-cyclohexan]-3(2H)-one derivatives as PARP-1 inhibitors: Design, synthesis and biological evaluation.
    Li S; Li XY; Zhang TJ; Zhu J; Liu KL; Wang DP; Meng FH
    Bioorg Chem; 2021 Jun; 111():104840. PubMed ID: 33780687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities.
    Liu G; Song S; Shu S; Miao Z; Zhang A; Ding C
    Eur J Med Chem; 2015 Oct; 103():17-28. PubMed ID: 26318055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
    Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
    Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
    Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
    Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and semisynthesis of novel fredericamycin A derivatives with an improved antitumor profile.
    Abel U; Simon W; Eckard P; Hansske FG
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3292-7. PubMed ID: 16621542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of New Bis-Spiropyrazoles as Antitumor Agents under Ultrasound Irradiation.
    Abdel Hafez NA; Hassaneen HME; Farghaly TA; Riyadh SM; Elzahabi HSA
    Mini Rev Med Chem; 2018; 18(7):631-637. PubMed ID: 28901853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convenient one-pot synthesis, anti-mycobacterial and anticancer activities of novel benzoxepinoisoxazolones and pyrazolones.
    Saidachary G; Veera Prasad K; Divya D; Singh A; Ramesh U; Sridhar B; China Raju B
    Eur J Med Chem; 2014 Apr; 76():460-9. PubMed ID: 24607876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones.
    Abdel-Aziz AA; El-Azab AS; El-Subbagh HI; Al-Obaid AM; Alanazi AM; Al-Omar MA
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2008-14. PubMed ID: 22318157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors.
    Liu R; Zhang Z; Yang H; Zhou K; Geng M; Zhou W; Zhang M; Huang X; Li Y
    Eur J Med Chem; 2019 Oct; 180():171-190. PubMed ID: 31306905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
    Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
    Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of unprecedented steroidal spiro heterocycles as potential antiproliferative drugs.
    Romero-Hernández LL; Merino-Montiel P; Meza-Reyes S; Vega-Baez JL; López Ó; Padrón JM; Montiel-Smith S
    Eur J Med Chem; 2018 Jan; 143():21-32. PubMed ID: 29172080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study.
    Rana S; Blowers EC; Tebbe C; Contreras JI; Radhakrishnan P; Kizhake S; Zhou T; Rajule RN; Arnst JL; Munkarah AR; Rattan R; Natarajan A
    J Med Chem; 2016 May; 59(10):5121-7. PubMed ID: 27077228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.